Keep an eye on CRISPR Therapeutics (CRSP), we said on Nov. 2. “The gene editing stock is starting to take off after a favorable US FDA panel review of the drug exa-cel for sickle-cell disease. Now, should the US FDA approve it on the panel’s vote, we could be looking...
Keep an eye on Intel (INTC). With strong earnings growth, CEO Pat Gelsinger just bought another 6,775 INTC shares for about $250,000 between October 31 and November 1. While technically stretched, we’re waiting to see if the INTC stock can break above prior resistance...
Gold prices could rally well above $2,000, near-term. For one, investors are turning to gold as a safe haven with geopolitical issues raging out of control. Two, gold still has plenty of room to run higher, especially with the U.S. debt problem creating further...
Keep an eye on C3.ai (AI). After months of consolidating around $25, the AI stock broke out, and could potentially refill its bearish gap around $32.50 next. President Biden’s executive order on artificial intelligence could also boost the stock -- especially if the...
Investors may want to keep an eye on Take-Two Interactive (TTWO). The gaming stock could push even higher, as millions of gamers wait for the release of Grand Theft Auto VI—one of the most anticipated game releases. Helping, CEO Strauss Zelnick hinted at a possible...
Keep an eye on CRISPR Therapeutics (CRSP). The gene editing stock is starting to take off after a favorable US FDA panel review of the drug exa-cel for sickle-cell disease. Now, should the US FDA approve it on the panel’s vote, we could be looking at the first...
by Ian Cooper It’s been another volatile year. Thanks to the fear of rising interest rates, potential recession, tighter credit issues, higher oil prices, and incessant geopolitical issues, it’s been chaotic. Worse, 71% of Americans say the U.S. is headed in the wrong...
Meta Platforms (META) was crushed the other day on ad spending in the fourth quarter. However, it now appears the pullback is a bit overdone. Even analysts like Wedbush Securities’ Dan Ives see the pullback as an opportunity, noting, “I believe this tech sell-off...
Oversold shares of American Express (AXP) look interesting. For one, the AXP stock is technically oversold at support dating back to late 2022, early 2023. It’s also technically stretched on RSI, MACD, and Williams’ %R, and appears overdue for a bounce back. Two,...
Many times, when Occidental Petroleum dips, Warren Buffett’s Berkshire Hathaway will buy. In fact, the firm just bought another 3.9 million shares, increasing its stake to 228 million shares, which is worth about $14.5 billion. That now gives Buffett a 25.8% stake in...